Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Life Sci ; 344: 122581, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38514004

ABSTRACT

Hypocretin is synthesized exclusively in the hypothalamus and distributes inputs to several areas of the brain, which may play an important role in depression. Our previous study showed that hypocretin-1 was increased in the lateral hypothalamus in female patients with depression compared to female controls. Estrogen acts through estrogen receptor (ER)α and ERß. We studied the possibility of a direct action of estrogen receptors on the expression of human hypocretin. We found that hypocretin-1 plasma levels were significantly higher in female patients with depression than in female controls. Female depression estrogen receptors and hypocretin are colocalized in the human lateral hypothalamus, PC12, and SK-N-SH cells. The estrogen receptor response elements (ERE) that exist in the hypocretin promoter region may directly regulate the gene expression of hypocretin. The synchronicity of change of hypocretin and estradiol both in hypothalamus and plasma was verified in female rats. In the presence of estradiol, specific binding occurs between the recombinant human ER and hypocretin-ERE. Expression of ER combined with estradiol repressed hypocretin promoter activity via the ERE. In conclusion, we found that estradiol may directly affect hypocretin neurons in the human hypothalamus via ER binding to the hypocretin-ERE, which may lead to the sex-specific pathogenesis of depression.


Subject(s)
Estrogens , Receptors, Estrogen , Male , Humans , Rats , Female , Animals , Orexins/genetics , Receptors, Estrogen/genetics , Receptors, Estrogen/metabolism , Estrogen Receptor alpha/genetics , Estrogen Receptor alpha/metabolism , Estradiol/metabolism , Estrogen Receptor beta/metabolism
2.
Psychiatry Clin Neurosci ; 77(3): 149-159, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36436207

ABSTRACT

AIM: Clinical and preclinical studies suggest that alterations in the peripheral and brain immune system are associated with the pathophysiology of depression, also leading to changes in local glucose metabolism in the brain. Here, the authors identified Yin-Yang 1 (YY1), a transcription factor closely associated with central and peripheral inflammation. METHODS: Plasma levels of YY1, interleukin (IL) 6, and IL-1ß in major depressive disorder (MDD) were collected before and after treatment with vortioxetine, and correlation with clinical and cognitive scores was studied. Chronic unpredictable mild stress was treated with vortioxetine. Micropositron emission tomography (microPET) was used to analyze glucose metabolism and mRNA, and the protein level of the YY1-nuclear factor κB (NF-κB)-IL-1ß inflammatory pathway were measured in related brain regions. RESULTS: Plasma levels of YY1 and IL-1ß were significantly increased in MDD and decreased after treatment with vortioxetine. Meanwhile, the level of YY1 in plasma was negatively correlated with cognitive functions in patients with MDD and positively correlated with the level of IL-1ß in plasma. Compared with the control group, in chronic unpredictable mild stress rats, (microPET) analysis showed that the decrease of glucose metabolism in the hippocampus, entorhinal cortex, amygdala, striatum, and medial prefrontal cortex was reversed after treatment. mRNA and protein level of related molecular in YY1-NF-κB-IL-1ß inflammatory pathway decreased in the hippocampus and was reversed by vortioxetine. CONCLUSION: The current study suggests that the YY1-NF-κB-IL-1ß inflammatory pathway may play an essential role in both mood changes and cognitive impairment in depression, and may be associated with changes in glucose metabolism in emotion regulation and cognition. These findings provide new evidence for the inflammatory mechanisms of depression.


Subject(s)
Cognitive Dysfunction , Depressive Disorder, Major , Animals , Rats , Cognitive Dysfunction/complications , Depression/drug therapy , Depressive Disorder, Major/complications , Glucose , Inflammation/complications , Interleukin-6 , NF-kappa B , RNA, Messenger/metabolism , Transcription Factors , Vortioxetine , Yin-Yang , YY1 Transcription Factor/genetics , YY1 Transcription Factor/metabolism
3.
Psychiatry Res ; 317: 114838, 2022 11.
Article in English | MEDLINE | ID: mdl-36103758

ABSTRACT

Major depressive disorder (MDD) is a devastating mental illness and the leading cause of disability worldwide. Previous studies have suggested that synaptic plasticity in the hippocampus plays an important role in depression pathogenesis. Reelin is expressed mainly in the frontal lobe and hippocampus, and is closely associated with neurodevelopment and synaptic plasticity. However, few studies have investigated its role in MDD combining clinical trials and animal experiments. We show that in a clinical trial, plasma reelin levels decreased in patients with first-episode drug-naïve MDD and increased after treatment; further, plasma reelin levels allowed to distinguish drug-naïve patients with first-episode MDD from healthy individuals. In rats, chronic mild and unpredictable stress led to a decrease in both reelin mRNA and protein levels in the hippocampus, which could be reversed by vortioxetine. Subsequent experiments confirmed that the reelin-ApoER2-NR2A /NR2B pathway regulates hippocampal synaptic plasticity and may be involved in depression or antidepressant responses. Our work contributes to a deeper understanding of MDD pathogenesis and provides new evidence that reelin should be considered a potential therapeutic target for MDD.


Subject(s)
Cell Adhesion Molecules, Neuronal , Depressive Disorder, Major , Animals , Rats , Cell Adhesion Molecules, Neuronal/genetics , Cell Adhesion Molecules, Neuronal/metabolism , Depression , Depressive Disorder, Major/metabolism , Extracellular Matrix Proteins/genetics , Extracellular Matrix Proteins/metabolism , Hippocampus/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Reelin Protein , Rodentia/metabolism , Serine Endopeptidases/genetics , Serine Endopeptidases/metabolism , Clinical Trials as Topic
4.
Front Neurosci ; 16: 884579, 2022.
Article in English | MEDLINE | ID: mdl-35873818

ABSTRACT

Overnutrition-related obesity has become a worldwide epidemic, and its prevalence is expected to steadily rise in the future. It is widely recognized that obesity exerts negative impacts on metabolic disorders such as type 2 diabetes mellitus (T2DM) and cardiovascular diseases. However, relatively fewer reports exist on the impairment of brain structure and function, in the form of memory and executive dysfunction, as well as neurogenerative diseases. Emerging evidence indicates that besides obesity, overnutrition diets independently induce cognitive impairments via multiple mechanisms. In this study, we reviewed the clinical and preclinical literature about the detrimental effects of obesity or high-nutrition diets on cognitive performance and cerebral structure. We mainly focused on the role of brain insulin resistance (IR), microbiota-gut-brain axis, and neuroinflammation. We concluded that before the onset of obesity, short-term exposure to high-nutrition diets already blunted central responses to insulin, altered gut microbiome composition, and activated inflammatory mediators. Overnutrition is linked with the changes in protein expression in brain insulin signaling, leading to pathological features in the brain. Microbiome alteration, bacterial endotoxin release, and gut barrier hyperpermeability also occur to trigger mental and neuronal diseases. In addition, obesity or high-nutrition diets cause chronic and low-grade systematic inflammation, which eventually spreads from the peripheral tissue to the central nervous system (CNS). Altogether, a large number of unknown but potential routes interact and contribute to obesity or diet-induced cognitive impairment. The challenge for future research is to identify effective interventions involving dietary shifts and personalized therapy targeting the underlying mechanisms to prevent and improve cognition deficits.

6.
Entropy (Basel) ; 20(11)2018 Oct 24.
Article in English | MEDLINE | ID: mdl-33266543

ABSTRACT

Information-theoretically provable unique true random numbers, which cannot be correlated or controlled by an attacker, can be generated based on quantum measurement of vacuum state and universal-hashing randomness extraction. Quantum entropy in the measurements decides the quality and security of the random number generator (RNG). At the same time, it directly determines the extraction ratio of true randomness from the raw data, in other words, it obviously affects quantum random bits generating rate. In this work, we commit to enhancing quantum entropy content in the vacuum noise based quantum RNG. We have taken into account main factors in this proposal to establish the theoretical model of quantum entropy content, including the effects of classical noise, the optimum dynamical analog-digital convertor (ADC) range, the local gain and the electronic gain of the homodyne system. We demonstrate that by amplifying the vacuum quantum noise, abundant quantum entropy is extractable in the step of post-processing even classical noise excursion, which may be deliberately induced by an eavesdropper, is large. Based on the discussion and the fact that the bandwidth of quantum vacuum noise is infinite, we propose large dynamical range and moderate TIA gain to pursue higher local oscillator (LO) amplification of vacuum quadrature and broader detection bandwidth in homodyne system. High true randomness extraction ratio together with high sampling rate is attainable. Experimentally, an extraction ratio of true randomness of 85.3% is achieved by finite enhancement of the laser power of the LO when classical noise excursions of the raw data is obvious.

SELECTION OF CITATIONS
SEARCH DETAIL
...